Studies from University of Toronto Update Current Data on COVID-19 [Differences In Mrna-1273 (Moderna) and Bnt162b2 (Pfizer-biontech) Sars-cov-2 Vaccine Immunogenicity Among Patients Undergoing Dialysis]

Source :: Vaccine Weekly. April 6, 2022, 878
Publication Year :: 2022
Abstract: 2022 APR 6 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Investigators discuss new findings in Coronavirus - COVID-19. According to news reporting originating from Toronto, [...]

Subjects :: Pfizer Inc.
University of Toronto
Comirnaty (Vaccine) -- Research -- Health aspects
Research
Health aspects
Coronaviruses -- Health aspects -- Research
COVID-19 vaccines -- Research
Medical research -- Health aspects
Vaccination -- Research -- Health aspects
Pharmaceutical industry -- Health aspects -- Research
COVID-19 -- Research
Messenger RNA -- Research -- Health aspects
Medicine, Experimental -- Health aspects

Tools